Normativa UEJul. 3, 2013
UE: revisan límites máximos de residuo para flurprimidol
On 05 April 2013 EFSA issued a draft reasoned opinion that was circulated to Member States’ experts for consultation. No comments were received by 07 June 2013 and the following conclusions are derived.
The toxicological profile of flurprimidol was evaluated in the framework of Directive 91/414/EEC, which resulted in an ADI and an ARfD being established at 0.003 mg/kg bw per d and 0.09 mg/kg bw, respectively.
Considering that the use of flurprimidol as a pesticide active substance is no longer authorised within the EU (authorisations for emergency situations in plant protection granted in application of Article 53 of Regulation (EC) No 1107/2009 are not considered in the context of this Reasoned Opinion), that no CXLs are available for this active substance and that no uses authorised in third countries were notified to the RMS, residues of flurprimidol are not expected to occur in any plant commodity due to a pesticide use. Although parent flurprimidol can be enforced in food of plant origin with an LOQ of 0.01 mg/kg in high water content commodities, the most relevant compound(s) that would occur following illegal use of flurprimidol cannot be identified by EFSA since data on primary crop and livestock metabolism are not available.
A risk assessment is in principle not required considering that the use of flurprimidol is no longer authorised in the EU and that no import tolerances have been notified but the default MRL of 0.01 mg/kg as defined by Regulation (EC) No 396/2005 provides a satisfactory level of protection for European consumers regarding parent flurprimidol. However, in the absence of data on plant and livestock metabolism, the occurrence of toxicologically relevant metabolites in case of illegal use can not be excluded, even if parent residues levels remain below the LOQ.
Based on the above assessment, the existing EU MRLs in plants commodities, exceeding the LOQ of 0.01 mg/kg are in principle no longer required. Considering however that the enforcement against potential illegal uses falls under the remit of risk managers, EFSA is not in a position to recommend whether the default MRL of 0.01 mg/kg, as defined by Regulation (EC) No 396/2005, should apply or whether the setting of a specific LOQ is necessary. Available data indicate that the default MRL of 0.01 mg/kg is sufficiently protective regarding parent flurprimidol but it could not be demonstrated that flurprimidol is an adequate indicator for enforcement against a potential illegal use.